Breast Cancer

The US Food and Drug Administration recently approved a biosimilar to Humira for the treatment of multiple inflammatory diseases in adult patients.

The US Food and Drug administration expanded the indication for Victoza, a GLP-1 analog originally approved in 2010.

The US Food and Drug administration expanded the indication for Victoza, a GLP-1 analog originally approved in 2010.

The US Food and Drug administration expanded the indication for Victoza, a GLP-1 analog originally approved in 2010.

The US Food and Drug Administration has expanded the approval of Faslodex, a hormonal therapy for the treatment of breast cancer first approved in 2002.

The US Food and Drug Administration has expanded the approval of Faslodex, a hormonal therapy for the treatment of breast cancer first approved in 2002.

The US Food and Drug Administration has expanded the approval of Faslodex, a hormonal therapy for the treatment of breast cancer first approved in 2002.

The FDA has approved the first and only treatment option for levodopa-induced dyskinesia in patients with Parkinson disease.

The FDA has approved the first and only treatment option for levodopa-induced dyskinesia in patients with Parkinson disease.

The FDA has approved the first and only treatment option for levodopa-induced dyskinesia in patients with Parkinson disease.